These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12868004)

  • 1. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans.
    Tang J; Mohr S; Du YD; Kern TS
    Curr Eye Res; 2003 Jul; 27(1):7-13. PubMed ID: 12868004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The changes of histology and biochemical parameters in retina of the patient with diabetic retinopathy].
    Tang J; An XL; Song HG; Bing H
    Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):689-91. PubMed ID: 16200860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular lesions in diabetes are distributed non-uniformly within the retina.
    Kern TS; Engerman RL
    Exp Eye Res; 1995 May; 60(5):545-9. PubMed ID: 7615020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.
    Zheng L; Du Y; Miller C; Gubitosi-Klug RA; Kern TS; Ball S; Berkowitz BA
    Diabetologia; 2007 Sep; 50(9):1987-1996. PubMed ID: 17583794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Mar; 114(3):306-10. PubMed ID: 8600891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels.
    Badr GA; Tang J; Ismail-Beigi F; Kern TS
    Diabetes; 2000 Jun; 49(6):1016-21. PubMed ID: 10866055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.
    Du Y; Smith MA; Miller CM; Kern TS
    J Neurochem; 2002 Mar; 80(5):771-9. PubMed ID: 11948240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice.
    Steinle JJ; Kern TS; Thomas SA; McFadyen-Ketchum LS; Smith CP
    Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril inhibits glucose accumulation in retinal cells in diabetes.
    Zhang JZ; Gao L; Widness M; Xi X; Kern TS
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):4001-5. PubMed ID: 12939321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model of diabetic retinopathy.
    Kern TS; Engerman RL
    Arch Ophthalmol; 1996 Aug; 114(8):986-90. PubMed ID: 8694735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of retinal GLUT1 in diabetes by ubiquitinylation.
    Fernandes R; Carvalho AL; Kumagai A; Seica R; Hosoya K; Terasaki T; Murta J; Pereira P; Faro C
    Mol Vis; 2004 Aug; 10():618-28. PubMed ID: 15359219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
    Kern TS; Engerman RL
    Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability.
    Carmo A; Cunha-Vaz JG; Carvalho AP; Lopes MC
    Nitric Oxide; 2000 Dec; 4(6):590-6. PubMed ID: 11139367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Notch3 Deficiency in Diabetes-Induced Pericyte Loss in the Retina.
    Liu H; Zhang W; Lilly B
    J Vasc Res; 2018; 55(5):308-318. PubMed ID: 30347392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro.
    Podestà F; Romeo G; Liu WH; Krajewski S; Reed JC; Gerhardinger C; Lorenzi M
    Am J Pathol; 2000 Mar; 156(3):1025-32. PubMed ID: 10702418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
    Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
    J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.